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ABSTRACT
Histone demethylases have emerged as key regulators of biological processes. The H3K9me2
demethylase plant homeo domain ﬁnger protein 8(PHF8), for example, is involved in neuronal
differentiation, but its potential function in the differentiation of embryonic stem cells (ESCs) to
cardiomyocytes is poorly understood. Here, we explored the role of PHF8 during mesodermal
and cardiac lineage commitment of mouse ESCs (mESCs). Using a phf8 knockout (ph8-/Y) model,
we found that deletion of phf8 in ESCs did not affect self-renewal, proliferation or early ecto-
dermal/endodermal differentiation, but it did promote the mesodermal lineage commitment
with the enhanced cardiomyocyte differentiation. The effects were accompanied by a reduction
in apoptosis through a caspase 3-independent pathway during early ESC differentiation, without
signiﬁcant differences between differentiating wide-type (ph81/Y) and ph8-/Y ESCs in cell cycle
progression or proliferation. Functionally, PHF8 promoted the loss of a repressive mark
H3K9me2 from the transcription start site of a proapoptotic gene pmaip1 and activated its tran-
scription. Furthermore, knockdown of pmaip1 mimicked the phenotype of ph8-/Y by showing
the decreased apoptosis during early differentiation of ESCs and promoted mesodermal and car-
diac commitment, while overexpression of pmaip1 or phf8 rescued the phenotype of ph8-/Y
ESCs by increasing the apoptosis and weakening the mesodermal and cardiac differentiation.
These results reveal that the histone demethylase PHF8 regulates mesodermal lineage and cell
fate decisions in differentiating mESCs through epigenetic control of the gene critical to pro-
grammed cell death pathways. STEM CELLS 2016;34:1527–1540
SIGNIFICANCE STATEMENT
Embryonic stem cells (ESCs) have the unique ability to differentiate into derivatives of all three
germ layers both in vitro and in vivo. Thus, ESCs provide a unique model for the study of early
embryonic development. We report here previously unrecognized effects of histone demethyl-
ase plant homeo domain finger protein 8 (PHF8) on mesodermal and early cardiac differentia-
tion. This effect is resulted from the regulation of PHF8 on apoptosis through activating the
transcription of pro-apoptotic gene pmaip1. These findings extend the knowledge in under-
standing of the epigenetic modification in apoptosis during ESC differentiation and of the link
between apoptosis and cell lineage decision as well as cardiogenesis.
INTRODUCTION
Embryonic stem cells (ESCs) have the unique abil-
ity to differentiate into derivatives of all three
germ layers both in vitro and in vivo. Due to this
plasticity, mechanisms controlling cell autono-
mous and regulatory events critical to in vivo
mammalian development have beneﬁtted from
the in vitro study of differentiating ESCs [1, 2].
Early embryogenesis and cavity formation as well
as early ESC differentiation, for example, are
accompanied by a reduction in proliferation and
increased apoptosis [3–5]. Withdrawal of leuke-
mia inhibitory factor (LIF) from mouse embryonic
stem cells (mESCs) cultivated in vitro causes
approximately 20%-30% of the cells to die by
spontaneous (constitutive) apoptosis [4, 5]. This
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occurs secondary to the induction of cleaved caspase 3 [3] and
apoptosis-inducing factor (AIF)-complex proteins [6]. Blockade of
spontaneous apoptosis in vitro by a p38 mitogen-activated pro-
tein kinase (MAPK) inhibitor alters the differentiation markers
and increases the abundance of both antiapoptotic proteins (Bcl-
2, Bcl-XL) and Ca
21-binding proteins [4, 7]. In addition, Ca21
released from type 3 inositol 1, 4, 5-trisphosphate receptors
(IP3R3) negatively regulates this apoptotic response, which in
turn modulates the mesodermal lineage commitment of early dif-
ferentiating mESCs [5]. These ﬁndings explain, in part, how apo-
ptosis contributes to speciﬁc lineage commitment during early
development. However, in contrast to the relatively advanced
knowledge of signaling pathways [8], little is known about the
contribution of epigenetic regulators, especially, histone lysine
demethylases (KDMs), in the regulation of apoptosis during ESC
differentiation and how the affected programmed cell death by
KDMs contributes to the lineage commitment.
Epigenetic regulators and dynamic histone modiﬁcations
by KDMs are emerging as important players in ESC fate deci-
sions [9]. Histone modiﬁcations coordinate transient changes
in gene transcription and help maintaining differential pat-
terns of gene expression during differentiation [10–13]. The
molecular and biological functions of many KDMs, however,
remain enigmatic during ESC differentiation. PHF8, an X-linked
gene encoding an evolutionarily conserved histone demethyl-
ase harboring an N-terminal plant homeo domain (PHD) and
an active jumonji-C domain (JmjC), is able to catalyze deme-
thylation from histones [14, 15]. It is actively recruited to and
enriched in the promoters of transcriptionally active genes
[14], and it functions to maintain the active state of rRNA
through the removal of the repressive H3K9me2 methylation
mark at the active rRNA promoters. Mutation of PHF8 is asso-
ciated with X-linked mental retardation with cleft lip/cleft pal-
ate in human [16–18]. Knockdown of phf8 in mouse
embryonic carcinoma P19 cells impairs neuronal differentia-
tion [19] and leads to brain defects in zebraﬁsh by directly
regulating the expression of the homeo domain transcription
factor MSX1/MSXB [20]. However, the precise function of
PHF8 in the regulation of lineage differentiation derived from
other germ layers remains to be identiﬁed.
Here, we report previously unrecognized effects of the
PHF8 histone demethylase on germ layer commitment and
differentiation of mESCs. The results are based on an assess-
ment of early steps of differentiation to mesodermal lineages
and cardiomyocytes using phf8 knockout (phf8-/Y) and wild-
type (phf81/Y) mESCs. The data show that PHF8 regulates
gene transcription of a proapoptotic gene pmaip1 (also
named Noxa) [21]. Activation or repression of pmaip1 con-
trolled by PHF8 ultimately determines mESC lineage commit-
ment through the regulation of caspase 3-independent
apoptosis during mesodermal and cardiac differentiation. Our
data reveal that PHF8-mediated the demethylation of histone
proteins coordinates ESC lineage commitment through the
regulation of apoptosis in early differentiating ESCs.
MATERIALS AND METHODS
ESC Culture and In Vitro Differentiation
Undifferentiated Phf81/Y and Phf8-/Y mESCs were maintained
on mitomycin C-inactivated mouse embryonic ﬁbroblast (MEF)
feeder layers in the presence of LIF (Millipore, Temecula, CA,
1,000 U/ml). The mESC differentiation was performed using a
hanging drop method as previously described [5, 22]. Speciﬁc
ectodermal [23] and endodermal [24] differentiation of mESCs
was performed as previously reported.
Generation of phf8 Knockout mESCs
To generate Phf8 knockout mESCs, the targeting vector carry-
ing a FRT-ﬂanked neomycin resistant gene and loxP-ﬂanked
exons 7 and 8 of Phf8 as well as an HSV-TK cassette was con-
structed as shown in Supporting Information Figure S1A. The
vector was electroporated into SCR012 mESCs. The mESCs
with the FRT sites were selected by G418 followed by Cre
mediated recombination of loxP sites to generate the Phf8-/Y
mESCs with deleted exons 7 and 8 in the X-chromosome (Sup-
porting Information Fig. S1A).
Generation of phf8 and pmaip1 Overexpressing
mESC Lines
Full-length mouse pmaip1 cDNA was generated from mESC
RNA by RT-PCR. A cDNA of human PHF8 (hPHF8) was ampli-
ﬁed from a plasmid encoding hPHF8 isoform 1 [19]. Both
were cloned into the pCDH-EF1-MCS-T2A-Puro lentiviral vec-
tors, respectively (System Biosciences, CA). The viral packaging
was performed in 293FT cells after transfection with lipofect-
amine3000 according to the manufacture’s protocol (Invitro-
gen). A wild-type pCDH-EF1-MCS-T2A-Puro vector was used as
a negative control (NC). For viral infections, phf8-/Y mESCs
were infected with lentiviruses for 6 hours. After 48 hours,
infected cells were selected with puromycin for 1 week to
generate the stable pmaip1-ovexpressing phf8-/Y mESCs (phf8-
pmaip1-/1 mESCs), hPHF8-overexpressing phf8-/Y mESCs (phf8-
hPHF8-/1 mESCs), and NC phf8-/Y mESCs (phf8-NC-/1 mESCs).
All plasmids were veriﬁed by DNA sequencing.
Cell Transfection of Small Interfering RNA
Negative control (si-NC) and pmaip1 small interfering RNAs (siRNAs)
(si-Pmaip1) were synthesized by Gene Pharma (si-NC, 50-
UUCUCCGAACGUGUCACGUTT-30 and 50-ACGUG- ACACGUUCGGA-
GAATT-30; si-Pmaip1, 50-GGAUUGGAGACAAAGUGAAT- T-30 and 50-
UUCACUUUGUCUCCAAUCCTT-30). si-Pmaip1 and si-NC were trans-
fected into ESCs using DharmaFECT1 (Thermo-ﬁsher,Waltham, MA)
according to the manufacturer’s instructions.
Immunocytochemical Staining
Undifferentiated mESCs were stained using an ALP substrate kit
III (Vector Laboratories, Burlingame, CA) according to the manu-
facturer’s instructions. Immunoﬂuorescence assays were per-
formed as described previously [25]. Brieﬂy, attached cells and
embryoid bodies (EBs) were harvested at indicated stages, ﬁxed
with 4% paraformaldehyde, permeabilized in 0.3% Triton X-100
(Sigma-Aldrich, St. Louis, MO), blocked in 10% normal goat
serum (Vector Laboratories), and then stained with antibodies
to stage-speciﬁc embryonic antigen 1 (SSEA-1) (Cat No. 13-
8813-82, eBioscience, San Diego, CA, 1:200), SRY (sex determin-
ing region Y)-box 2 (SOX2) (Cat No. MAB2018, R&D, Minneapo-
lis, MN, 1:200), a-actinin (Cat No. A7732, Sigma-Aldrich, 1:200),
cardiac troponin T (TNNT2) (Cat No. ab8295, Abcam, La Jolla,
CA, 1:300), or H3K9me2 (Cat No. ab1220, Abcam, 1:200). Anti-
body labeling was visualized using Alexa Fluor 594 goat anti-
mouse IgM (Cat No. A-24921, Invitrogen, Carlsbad, CA, 1:1000),
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and DyLight 488- or DyLight 549-conjugated secondary antibod-
ies (all from Jackson Immunoresearch,West Grove, PA, 1:1,000).
Nuclei were counterstained with Hoechst 33258 (Sigma-Aldrich,
1:2,000), and cells were analyzed using a Nikon T1 2000 ﬂuores-
cence microscope. EBs in suspension culture were ﬁxed in 4%
paraformaldehyde, embedded in OCT and taken at 20-25 lm
thicknesses. The immunostained slices were imaged using a
Leica TCS SP2 confocal laser-scanning microscope.
Flow Cytometry Analysis
Tripsinized undifferentiated or differentiating cells were pre-
pared as described [26], and incubated with antibodies to
FLK-1 (Cat No. 560070, BD Biosciences, Bedford, MA, 1:200),
NESTIN (Cat No. 556309, BD Biosciences, 1:50), SOX17 (Cat
No. MAB1924, R&D, 1:25), cardiac troponin T (TNNT2) (Cat
No. ab8295, Abcam, 1:200), or a-myosin heavy chain (MYH6)
(Cat No. ab50967, Abcam, 1:200). The antibody labeling was
visualized using anti-mouse IgG-PE or IgG-PEcy7 (eBioscience,
both 1:200). Cells were then analyzed by ﬂow cytometry (FAC-
Star Plus Flow Cytometer, Becton-Dickinson, San Jose, CA).
Cell Viability Assays
A total of 1,000 cells/well were planted in 96-well plates and
cultured for 7 days in the presence or absence of LIF and
MEF. At indicated times, 10ll of 5mg/ml MTT (3-(4,5-dime-
thylthiazolyl-2)-2,5-diphenyltetrazolium bromide, Sangon Bio-
tech, Shanghai, China) solution was added and incubated for
4 hours. DMSO (Sigma-Aldrich) was then added to solubilize
the formazan product and the absorbance was measured at
570 nm.
Cell Proliferation Assays
For bromodeoxyuridine (BrdU) analysis, ESCs were dissociated
into single cells and incubated with 100lM BrdU (Sigma-
Aldrich) for 30 minutes. BrdU positive cells were analyzed by
ﬂow cytometry (FACStar Plus Flow Cytometer, Becton-Dickin-
son) using an anti-BrdU APC-conjugated antibody (Cat No.
552598, BD Biosciences, 1:200) according to the manufac-
turer’s instructions.
Cell Cycle Analysis
ESCs were dissociated into single cells, ﬁxed with 70% ethanol
and stained with 50lg/ml propidium iodide (PI) containing
0.1mg/ml RNase A (both from Sigma-Aldrich). The cells were
then analyzed by ﬂow cytometry (FACStar Plus Flow Cytome-
ter, Becton-Dickinson) to detect the cell cycle distribution of
G1, S, and G2/M phases.
Apoptosis Assays
Cells were harvested at the indicated times and stained with
an Annexin V-FITC Apoptosis Detection Kit (BD Bioscience) to
detect early apoptotic cells according to the manufacturer’s
instructions. Terminal deoxynucleotidyl-transferase-mediated
dUTP-biotin nick end labeling (TUNEL) assay was used to mon-
itor late stage apoptosis with the in situ Cell Death Detection
Kit (Roche, Mannheim, Germany), according to the manufac-
turer’s instructions. Annexin V signal and TUNEL signal were
detected by ﬂow cytometry (FACStar Plus Flow Cytometer,
Becton-Dickinson). DNA Laddering assay was performed using
the Apoptotic DNA Ladder Kit (Applygen, Beijing, China) and
analyzed on 1.5% agarose gels.
RNA Extraction, Reverse Transcription-PCR and
Quantitative RT-PCR
Total RNA was isolated using Trizol (Invitrogen) and analyzed
by reverse transcription-PCR (RT-PCR) and quantitative RT-PCR
(qRT-PCR) as described [26]. The transcripts of m28s and
gapdh were used for internal controls. The RT-PCR primers
are listed in Supporting Information Table S1, and the qRT-
PCR primers are listed in Supporting Information Table S2.
Western Blot Assay
Experiments were performed as described [5]. Brieﬂy, cells
were lysed in a lysis buffer and 30lg of protein extract super-
natant was used for Western blots. Blots were incubated with
the primary antibody against H3K9me2 (Cat No. ab1220,
Abcam, 1:1,000), PHF8 (Cat No. ab36068, Abcam, 1:500), b-
actin (Cat No. BM0627, Boster, Wuhan, China, 1:4,000), cas-
pase 3 (Cat No. 9662, Cell Signaling Technology, Beverly, MA,
1:500), H3 histone (Cat No. 4620, Cell Signaling Technology,
1:2,000), or Poly (ADP-ribose) polymerase 1 (PARP1) (Cat No.
9542, Cell Signaling Technology, 1:1,000). The membranes
were then incubated with IRDye 680LT Donkey anti-Rabbit IgG
(Cat No. 926-68023, Li-COR Biosciences, Lincoln, NE) or IRDye
800LT Donkey anti-Mouse IgG (Cat No. 926-32212, Li-COR Bio-
sciences) as secondary antibodies and visualized on an Odys-
sey Infrared Imager (Li-COR Biosciences).
mRNA Microarray Analysis
Three replicates from either phf81/Y or phf8-/Y ESCs were
used for RNA extraction. Quality-assessed RNA samples were
supplied for a whole mouse gene expression microarray using
GeneChip Mouse Genome 430 2.0 (Affymetrix, Santa Clara,
CA). Eighteen raw data ﬁles generated by the Affymetrix scan-
ner passed data quality control were further performed with
RMA normalization through the Affymetrix expression con-
sole. Further analysis was performed using SAM (signiﬁcance
analysis of microarrays) software [27], and the hierarchical
average linkage clustering was performed using Cluster ver-
sion 3.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) experiments were per-
formed using a Simple ChIPTM Enzymatic Chromatin IP Kit
(Cell Signaling Technology) according to the manufacturer’s
instructions. Protein-DNA complexes were immunoprecipitated
with antibodies against PHF8 (Cat No. ab36068, Abcam),
H3K9me2 (Cat No. ab1220, Abcam), and normal rabbit IgG
(Cat No. 2729, Cell Signaling Technology). The puriﬁed DNA
was quantiﬁed by qRT-PCR with SYBR Green PCR reagents
(Toyobo, Osaka, Japan) to detect the enrichment of pmaip1
with the speciﬁc primers 50-GTCCCGATAAAATGCGAGAG-30 (for-
ward) and 50-GGGAGACTA-AGGTCCCCAAT-30 (reverse), and
normalized to the total input control.
Statistical Analysis
Data analysis was performed using Microsoft GraphPad Prism
5 (GraphPad Software, LA Jolla, CA). The data were shown as
mean1 SEM. The statistical signiﬁcance of differences was
estimated by ANOVA or Student’s t test as appropriate.
p< .05 was considered to be statistically signiﬁcant.
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RESULTS
Deletion of phf8 Promotes Mesodermal and Cardiac
Lineage Commitment
The PHF8 protein was detectable in undifferentiated ESCs,
but its abundance signiﬁcantly increased within one day of
LIF withdrawal. Then it gradually decreased to a level at day
5 lower than that observed in the undifferentiated ESCs
(Fig. 1A).
To determine the signiﬁcance of phf8 gene expression on
ESC fate decision, we knocked out the X-chromosome-
encoded phf8 gene in one allele of male SCR012 ESCs by
deletion of exons 7 and 8 through Cre-mediated recombina-
tion (Supporting Information Fig. S1A). Gene inactivation was
conﬁrmed by the lack of Phf8 mRNA and PHF8 protein expres-
sion in these targeted ESCs (Supporting Information Fig. S1B).
Transcripts for pluripotency marker genes nanog, rex1 (zfp42),
sox2, and oct4 (pou5f1) were not signiﬁcantly different
between phf81/Y and phf8-/Y ESCs (Fig. 1B). No signiﬁcant dif-
ference was observed in cell morphology (Supporting Informa-
tion Fig. S1C) of undifferentiated phf81/Y and phf8-/Y ESCs or
in alkaline phosphatase activity (Supporting Information Fig.
S1D). Immunoﬂuorescence staining conﬁrmed that the expres-
sion of pluripotency marker SOX2 and SSEA-1 did not differ
between the phf81/Y and phf8-/Y ESCs (Supporting Information
Fig. S1E). These results indicate that phf8 may be dispensable
for normal growth and maintenance of mESCs.
We then analyzed the role of PHF8 in the mesodermal
and cardiac lineage commitment. By microarray analysis of
differentiating phf81/Y and phf8-/Y cells from days 0, 1, to 3.5,
we found a signiﬁcant decrease in transcripts for pluripotency
markers, accompanied by a signiﬁcant increase in transcripts
for ectoderm, mesoderm and endoderm, while in phf8-/Y cells
some transcripts for mesodermal and cardiac lineage commit-
ment were signiﬁcantly enhanced compared with those in
phf81/Y cells (Supporting Information Fig. S2A). These
differentiation-dependent changes in transcript abundance
were conﬁrmed by qRT-PCR for early mesodermal markers
brachyury (T) [28], goosecoid (gsc), eomes [29], and mesp1
[30], cardiovascular progenitor marker ﬂk-1 [31, 32] and neu-
ropilin 1 (nrp1) [33]. Early cardiac transcription factors, includ-
ing myocyte enhancer factor 2C (mef2c) [34], hand1 [35], and
tbx5 [36, 37] were also up-regulated in phf8-/Y cells at differ-
entiation day 5, while no difference in the expression levels
of pluripotent markers oct4 (Fig. 1C), rex1, and nanog (Sup-
porting Information Fig. S2B) were detected between phf81/Y
and phf8-/Y cells at the time points examined.
Because mESCs can differentiate into all three germ
layers, we also examined whether phf8 affected ectodermal
and endodermal differentiation. qRT-PCR analysis did not
show any signiﬁcantly difference in the expression of early
ectodermal markers nestin and fgf5 between the phf81/Y and
phf8-/Y cells (Fig. 1D). Moreover, in the induced early ectoder-
mal differentiation system [23], the expression of ectodermal
markers nestin, fgf5, and pax6 were comparable between the
phf81/Y and phf8-/Y cells (Supporting Information Fig. S3A).
Besides, the expression of endodermal markers afp, foxa2,
sox17, and gata4 were not signiﬁcantly different between the
phf81/Y and phf8-/Y cells (Fig. 1E). Consistently, the expression
of endodermal markers foxa2, sox17, and gata4 were compa-
rable during induced endodermal differentiation [24] between
the phf81/Y and phf8-/Y cells (Supporting Information Fig.
S3B). Thus, phf8 appears not to affect early ectodermal and
endodermal differentiation.
The increased mesodermal and cardiac marker expressions
were associated with a signiﬁcant increase in the total num-
ber of cardiac progenitors and cardiomyocytes in differentiat-
ing phf8-/Y cells. By ﬂow cytometry analysis, marked increases
in the population of FLK-1 positive (FLK-11) cells were
detected in phf8-/Y cells at differentiation day 3 and day 4
(Fig. 2A). Consistently, the percentage of contracting EBs was
higher in phf8-/Y cells than in phf81/Y cells (Fig. 2B). The tran-
scripts for progenitor marker nrp1, early cardiac transcription
factor tbx5, and cardiac speciﬁc genes tnnt2, myh6, myl2, and
gja1 were higher in phf8-/Y EBs than those in phf81/Y ones
(Fig. 2C). The areas of immunostained EBs positive for the car-
diac cytoskeletal and myoﬁlamental proteins a-actinin and
TNNT2 were also greater in phf8-/Y than in phf81/Y EBs (Fig.
2D). Flow cytometry analysis of MYH61 (Fig. 2E) and TNNT21
(Fig. 2F) cells at differentiation day 9 further conﬁrmed the
increase of cardiomyocytes in phf8-/Y cells. Taken together,
these data indicate that the phf8 deletion facilitates the dif-
ferentiation of mesodermal and cardiac linage commitment.
PHF8 Inactivation Increases Cell Viability but not
Proliferation of the Differentiating ESCs
Differentiation of both phf81/Y and phf8-/Y ESCs via EB forma-
tion produced normal round shaped EBs but, by day 3, phf8-/Y
EBs were larger than those generated from phf81/Y ESCs, and
the size differences were visibly obvious at differentiation
days 5 and 7 (Fig. 3A). Although no signiﬁcant differences in
cell viability could be demonstrated between undifferentiated
phf81/Y and phf8-/Y ESCs (Fig. 3B), the viability of phf8-/Y cells
was signiﬁcantly greater than that in phf81/Y cells at differen-
tiation days 3 to 7 (Fig. 3C). However, no signiﬁcant change in
BrdU staining was detected by ﬂow cytometry between
phf81/Y and phf8-/Y ESCs at differentiation days 0, 3, or 5 (Fig.
3D). Moreover, no signiﬁcant difference in the cell cycle distri-
bution between the differentiating Phf81/Y and Phf8-/Y ESCs
was detected, although the percentage of cells in S phase
gradually decreased while those in G1 phase increased upon
differentiation (Fig. 3E). Knockout of phf8 thus increases cell
numbers in the early differentiating ESCs through the
improvement of cell viability without changes in cell prolifera-
tion or cell cycle progression.
PHF8 Regulates Apoptosis During the Early
Stage of Cardiac Lineage Commitment
We then examined whether cell death might account for the
differences in the cell viability observed between the differen-
tiating phf81/Y and phf8-/Y ESCs. In undifferentiated ESCs, no
signiﬁcant difference was demonstrated with Annexin V (an
early apoptosis marker) staining, TUNEL assay, total DNA frag-
mentation or caspase 3 protein cleavage between phf81/Y and
phf8-/Y cells (Fig. 4A--4C, 4E). In contrast, Annexin V staining
(Fig. 4A) and TUNEL assay (Fig. 4B) showed signiﬁcant
decreases in the number of apoptotic cells in phf8-/Y ESCs at
differentiation days 3 and 5 compared with those in phf81/Y
cells. Genomic DNA fragmentation with a pattern typical for
apoptosis was detected in phf81/Y cells at differentiation days
3 and 5, but it was reduced in phf8-/Y cells at the same time
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Figure 1. Plant homeo domain ﬁnger protein 8 (PHF8) regulates the mesodermal and early cardiac differentiation of mouse embryonic stem
cells (mESCs). (A): Western blot analysis of PHF8 expression in undifferentiated and differentiating ESCs. n5 3. (B): quantitative RT-PCR (qRT-
PCR) analysis of pluripotency markers nanog, rex1, sox2, and oct4. n5 8. (C): qRT-PCR analysis of gene expression of pluripotency marker oct4;
early mesodermal markers brachyury (T), gsc, eomes, andmesp1; cardiovascular progenitor markers ﬂk-1 and nrp1; and the cardiac transcription
factors hand1, tbx5, and mef2c during ESC differentiation. n5 5. (D): qRT-PCR analysis of the early ectodermal markers nestin and fgf5 during
ESC differentiation. n5 3. (E): qRT-PCR analysis of early endodermal markers afp, foxa2, sox17, and gata4 during ESC differentiation. n5 3.
Data are presented as mean6 SEM *, p< .05; **, p< .01; ***, p< .001 compared with the corresponding phf81/Y value.
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Figure 2. phf8 deletion promotes cardiac differentiation of mouse embryonic stem cells (mESCs). (A): Left, representative ﬂow cytome-
try plots showing FLK-1 expression at differentiation day 3 (n5 6), day 4 and day 5 (n5 3 each). Right, the quantiﬁcation of ﬂow cytom-
etry data. (B): Differentiation proﬁle of cardiomyocytes during embryoid bodies (EB) outgrowth. n5 6. (C): qRT-PCR analysis of ESCs for
the expression of cardiac markers at differentiation day 14. n5 3. (D): Immunoﬂuorescence analysis of TNNT2 and a-actinin in day 14
EBs. Scale bars5 400lm. (E) Flow cytometry analysis of MYH6 positive cells and (F) TNNT2 positive cells in day 9 EBs. n5 3 each. Data
are presented as mean6 SEM *, p< .05; **, p< .01; ***, p< .001 compared with the corresponding phf81/Y value.
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points (Fig. 4C). Moreover, approximately 35% of Annexin V1
cells were present in FLK-11/phf81/Y cells at differentiation
day 4, whereas only 9% of the cells were Annexin V1 in FLK-
11/phf8-/Y cells (Fig. 4D). The ratio of TUNEL1 to either
NESTIN1 (ectoderm) or SOX171 (endoderm) cells did not dif-
fer between the phf81/Y and phf8-/Y cells (Supporting Informa-
tion Fig. S3C, S3D). In addition, phf81/Y ESCs at differentiation
days 3 and 5 increased the caspase 3 cleavage (Fig. 4E, upper
and lower left panels) and the ratio of cleaved caspase 3 to
total caspase 3 protein (Fig. 4E, lower right panel). Unexpect-
edly, the ratio of cleaved caspase 3 to total caspase 3 in
phf8-/Y ESCs did not signiﬁcantly differ from that observed in
phf81/Y ones. Consistently, a signiﬁcant enhancement of the
downstream target PARP1 cleavage [38, 39] was observed at
differentiation days 3 and 5, but it was comparable between
the phf81/Y and phf8-/Y cells (Fig. 4F). These data suggest that
the cell death associated with phf8 function does not operate
through the conventional caspase 3-mediated apoptosis.
Figure 3. phf8 deletion increases cell viability in differentiating mouse embryonic stem cells (mESCs) without affecting cell proliferation.
(A): Left, phase-contrast images of embryoid bodies (EB) morphology during EB formation from ESCs. Scale bar5 200 lm. Right, the
diameter of EB formed from ESCs. (B): Cell viability of undifferentiated and (C): differentiating ESCs analyzed by MTT assay for seven
consecutive days. n5 3. (D): Flow cytometry analysis of BrdU positive proportion of undifferentiated (n5 4) and differentiating ESCs at
day 3 and day 5. n5 5 each. (E): Flow cytometry analysis of cell cycle distribution by propidium iodide (PI) staining at differentiation
day 3 (n5 6) and day 5 (n5 3). Data are presented as mean6 SEM *, p< .05; ***, p< .001 compared with the corresponding phf81/Y
value.
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Figure 4. Plant homeo domain ﬁnger protein 8 (PHF8) regulates apoptosis during the early mouse embryonic stem cells (mESC) differ-
entiation. (A): Left, representative ﬂow cytometry plots showing Annexin V (x-axis), and PI (y-axis) staining in ECSs at differentiation day
0 (n5 4), day 3 (n5 3) and day 5 (n5 7). Right, the quantiﬁcation of ﬂow cytometry data. (B): Flow cytometry detection of apoptotic
responses of TUNEL positive cells at differentiation day 0 (n5 3), day 3 (n5 4), and day 5 (n5 4). (C): DNA laddering analysis at differ-
entiation days 0, 3, and 5. n5 6 each. (D): Cells double stained with FLK-1 and Annexin V were analyzed by ﬂow cytometry at differen-
tiation day 4. n5 3. (E): Western blot analysis of caspase 3 during the mESC differentiation. b-actin was used as a loading control.
n5 4. (F): Western blot analysis of PARP1 expression during the differentiation. b-actin was used as a loading control. n5 4. Data are
presented as mean6 SEM *, p< .05; ***, p< .001 compared with the corresponding phf81/Y value; #, p< .05; ##, p< .01 compared
with the corresponding d0 value.
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pmaip1 is a Direct Target Gene of PHF8 in the
Early Differentiating ESCs
To understand how PHF8 might regulate apoptosis during
early ESC differentiation, we compared the proﬁles of
apoptosis-related gene transcripts in undifferentiated and
early differentiating phf81/Y and phf8-/Y ESCs using gene
expression microarrays. Among the apoptosis-related genes,
the transcript to pmaip1, a proapoptotic Bcl-2 family member
crucial in ﬁne-turning the cell death decision [21, 40–42], was
markedly increased during early differentiation of phf81/Y cells
but it was reduced in phf8-/Y cells at differentiation days 1
and 3.5 (Fig. 5A). These expression patterns were conﬁrmed
by qRT-PCR during cardiac differentiation (Fig. 5B), and the
results were consistent with the apoptotic pattern observed
during the early ESC differentiation (Fig. 4A--4C). In addition,
qRT-PCR analysis showed that the expression of pmaip1 did
not show any signiﬁcant difference between the phf81/Y and
phf8-/Y cells during the induced ectodermal (Supporting Infor-
mation Fig. S3E) or endodermal (Supporting Information Fig.
S3F) differentiation.
A direct link between the PHF8 and pmaip1 was then con-
ﬁrmed by ChIP analysis. We detected the endogenous binding
of PHF8 at the transcription start site (TSS, from 245 bp to
104 bp) of pmaip1 in phf81/Y ESCs and determined that bind-
ing was enhanced at differentiation day 3. The binding of
PHF8 was not detectable above the IgG control levels in
phf8-/Y cells (Fig. 5C). Global methylation (H3K9me2 normal-
ized to H3) was unchanged at differentiation days 3 and 5,
but it was signiﬁcantly enhanced at differentiation day 1 in
phf8-/Y cells (Fig. 5D). The augmentation of H3K9me2 methyla-
tion in phf8-/Y ESCs was then conﬁrmed by immunostaining at
differentiation day 1 (Fig. 5E). An increase in the repressive
mark of H3K9me2 was also observed at the TSS of pmaip1 in
the early differentiating phf8-/Y ESCs (Fig. 5F), indicating that
the PHF8 demethylase activity is actively involved in the regu-
lation of pmaip1 gene.
Transient Knockdown of pmaip1 Decreases Apoptosis
and Promotes Mesodermal and Cardiac Differentiation
To clarify the role of pmaip1 in mESC differentiation, we trans-
fected speciﬁc siRNAs against pmaip1 (si-Pmaip1) into phf81/Y
ESCs followed by EB formation. The negative control siRNA (si-
NC) did not alter pmaip1 transcript levels compared with
untreated (NT) cells, while si-Pmaip1 signiﬁcantly inhibited
pmaip1 transcripts by 74%-76% at differentiation days 0 and 1
(Fig. 6A-a). si-Pmaip1 cells had fewer TUNEL1 cells compared
with the NT and si-NC cells at differentiation day 3 in both
phf81/Y and phf8-/Y cells (Fig. 6A-b). We then examined whether
the pmaip1 knockdown inﬂuences mesodermal and early car-
diac differentiation. As shown in Figure 6B, the apoptosis of
FLK-11 cells was signiﬁcantly decreased in si-Pmaip1 mESCs
(Fig. 6B). The expression of T and gsc as well as nrp1 and ﬂk-1
were increased in si-Pmaip1 cells compared with those in NT
and si-NC cells at differentiation day 3. In addition, the expres-
sion of cardiac transcript factors mef2c and tbx5 was up-
regulated at differentiation day 5, and myh6 and tnnt2 were up-
regulated at differentiation day 9 (Fig. 6C). We also transfected
si-Pmaip1 into phf8-/Y ESCs. The expression of pmaip1 was
downregulated at differentiation day 0 and day 1 in phf8-/Y ESCs
with si-Pmaip1 (Supporting Information as Fig. S4A-a), accom-
panied by a decrease in TUNEL1 cells compared with NT and si-
NC (Fig. 6A-b), while Annexin V remained unchanged (Support-
ing Information Fig. S4A-b). The expression of nrp1 and ﬂk1 did
not signiﬁcantly change in phf8-/Y ESCs with si-Pmaip1 at differ-
entiation day 3, while mef2c was upregulated at differentiation
day 5, and myh6 was upregulated at differentiation day 9 (Sup-
porting Information as Fig. S4B). These results suggest that
downregulation of pmaip1 in phf8-/Y ESCs may not lead to as
robust of a phenotype as it did in phf81/Y ESCs. This difference
is likely due to the level of pmaip1 during early differentiation
of phf8-/Y ESCs was already decreased to a low level similar to
that observed in the undifferentiated cells (Fig. 5B). Taken
together, these data demonstrate that the decreased apoptosis
via down-regulation of pmaip1 contributes, at least partially, to
the phf8-/Y-facilitated mesodermal and cardiomyocyte
commitment.
Overexpression of pmaip1 or hPHF8 in phf8-/Y ESCs
Increases Apoptosis and Weakens Mesodermal and
Cardiac Differentiation
To further determine whether PHF8 contributes to mesoderm
and cardiac cell commitment through the regulation of apo-
ptosis via targeting pmaip1, we rescued the expression of
pmaip1 and phf8 in phf8-/Y ESCs by generating pmaip1-ovex-
pressing phf8-/Y mESCs (phf8-pmaip1-/1 mESCs) and hPHF8-
overexpressing phf8-/Y mESCs (phf8-hPHF8-/1 mESCs). The
qRT-PCR analysis conﬁrmed that the expression of hPHF8 or
pmaip1 was signiﬁcantly upregulated in the respective overex-
pressing cell lines (Supporting Information Fig. S4C). The
expression of pmaip1 in undifferentiated phf8-/Y mESCs was
not affected by hPHF8 overexpression. However, Pmaip1 tran-
scripts increased by differentiation day 3 in overexpressing
cells (Supporting Information Fig. S4D), indicating that PHF8
does regulate the expression of pmaip1 during differentiation.
Both TUNEL and Annexin V analysis revealed signiﬁcant
increases of apoptosis in phf8-pmaip1-/1 and phf8-hPHF8-/1
mESCs compared with the phf8-/Y and phf8-NC-/1 mESCs at
differentiation day 3 or day 4, accompanied by a higher apo-
ptosis ratio in FLK-11 cells (Fig. 6D). Moreover, the expression
of T and gsc as well as nrp1 and ﬂk-1 were signiﬁcantly
decreased in phf8-pmaip1-/1 and phf8-hPHF8-/1 mESCs at dif-
ferentiation day 3, followed by a down-regulation of mef2c
and tbx5 at differentiation day 5, and myh6 and tnnt2 at dif-
ferentiation day 9 (Fig. 6E). In addition, TUNEL analysis
showed no changes in the apoptotic responses either through
knockout or overexpression of phf8 compared with the corre-
sponding wild-type cells or phf81/Y cells during induced ecto-
dermal differentiation (Supporting information Fig. S4E). These
data are consistent with a regulatory role of phf8 on meso-
dermal and cardiac differentiation through targeting of
pmaip1.
DISCUSSION
This is the ﬁrst study to unravel a regulatory role of histone
demethylase in the differentiation of ESCs through the control of
apoptosis and subsequent effects on cell lineage commitment.
The role of PHF8 in the regulation of ESC differentiation to the
mesodermal lineage and cardiac differentiation is supported by
selective changes in RNA markers for mesodermal lineages, and
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an increase in cardiomyocyte progenitors and cardiomyocytes
(Figs. 1C, 2C). Moreover, deletion of phf8 speciﬁcally inhibits apo-
ptosis of Flk-11 mesodermal cells with a concomitant reduction
in Annexin V1 staining (Fig. 4D) and cardiac differentiation (Fig.
2B--E), while the ratio of TUNEL1 to either NESTIN1 (ectodermal
cells) or SOX171 (endodermal cells) cells does not differ between
the phf81/Y and phf8-/Y lines (Supporting Information Fig. S3C,
S3D). Consistently, the proportion of early apoptotic cells
Figure 5. pmaip1 is a direct target gene of plant homeo domain ﬁnger protein 8 (PHF8) in mouse embryonic stem cells (mESCs). (A):
Microarray gene expression heat map depicting the expression of apoptosis-related genes at differentiation days 0, 1 and 3.5 in phf81/Y
and phf8-/Y ESCs. The expression values in log2 scale were calculated and presented on the heat map with red representing highly abun-
dant transcripts and green representing poorly abundant transcripts. n5 3. (B): qRT-PCR analysis of pmaip1 during the ESC differentia-
tion. (C): ChIP assay of PHF8 around the TSS of pmaip1 in phf81/Y and phf8-/Y ESCs at differentiation days 0 and 3. n5 4 each. (D):
Western blot analysis of H3K9me2 and H3 in phf81/Y and phf8-/Y ESCs during the differentiation. H3 was used as a loading control.
n5 9. (E): H3K9me2 staining in phf81/Y and phf8-/Y embryoid bodies (EBs) at differentiation day 1. Scale bars5 25 lm. (F): ChIP assay of
H3K9me2 around the TSS of pmaip1 in phf81/Y and phf8-/Y ESCs at differentiation day 3. n5 4. Data are presented as mean6 SEM. *,
p< .05; **, p< .01; ***, p< .001 compared with the corresponding phf81/Y value or d0.
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(Annexin V1) in pmaip1-knockdown (Fig. 6B) is also decreased,
while pmaip1-overexpression or hPHF8-overexpression in phf8-/Y
cells increase the proportion of TUNEL1 and Annexin V1 cells
simultaneously with a reduction in mesodermal and cardiac dif-
ferentiation (Fig. 6D, 6E). These ﬁndings indicate that the PHF8
functions, at least partially, through regulation of apoptosis.
Figure 6. Plant homeo domain ﬁnger protein 8 (PHF8) regulates the mesodermal and cardiac differentiation through pmaip1. (A-a):
qRT-PCR analysis of the pmaip1 expression in phf81/Y ESCs after being transiently transfected with si-NC or si-Pmaip1. n5 4. (A-b):
Apoptosis cells were quantiﬁed by ﬂow cytometry analysis of TUNEL assay at differentiation day 3 in phf81/Y and phf8-/Y ESCs after
transient transfection with si-NC or si-Pmaip1. n5 3. (B): Cells double stained with FLK-1 and Annexin V were analyzed by ﬂow
cytometry at differentiation day 4. n5 4. (C): qRT-PCR analysis of the expression of T, gsc, ﬂk-1, nrp1, tbx5, mef2c, myh6, and tnnt2
in phf81/Y ESCs after transient transfection with si-NC or si-Pmaip1. n5 5. (D): Flow cytometry detection of TUNEL positive cells at
differentiation day 3, Annexin V positive cells and double stained FLK-1 and Annexin V at differentiation day 4 in phf8-/Y, phf8-NC-/1,
phf8-pmaip1-/1, and phf8-hPHF8-/1 mouse embryonic stem cells (mESCs). n5 4. (E): qRT-PCR analysis of the expression of T, gsc, ﬂk-
1, nrp1, tbx5, mef2c, myh6, and tnnt2 in phf8-/Y, phf8-NC-/1, phf8-pmaip1-/1, and phf8-hPHF8-/1 mESCs. n5 3. Data are presented as
mean6 SEM. *, p< .05; **, p< .01; ***, p< .001 compared with the corresponding phf81/Y or phf8-/Y value.
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It is well known that the regulation of apoptosis is of criti-
cal importance for proper ESC differentiation and embryo
development [8, 43]. ESC differentiation is regulated by apo-
ptosis induced by MAPK activation [7] and IP3R3-regulated
Ca21 release [5]. Previously only histone 3 lysine 4 methyl-
transferase MLL2 had been shown to activate the antiapop-
totic gene bcl2 to inhibit apoptosis during ESC differentiation
[44]. The data presented, here, extends and reveals the
importance of epigenetic controls in the activation of proa-
poptotic gene associated with ESC differentiation.
Mesodermal and cardiac differentiation have been shown
to be regulated by the histone demethylase ubiquitously tran-
scribed tetratricopeptide repeat, X chromosome (UTX) [13,
45] and jumonji domain–containing protein 3 (JMJD3) [12]
through transcriptional activation of mesodermal and cardiac
genes. These ﬁndings together with those presented in this
paper support the critical role of histone demethylases in line-
age commitment through regulatory mechanisms that control
the expression of core lineage speciﬁc transcription factors
and apoptotic genes. The decrease in apoptosis through dele-
tion of phf8 can be attributed to the maintenance of repres-
sive H3K9me2 mark on the TSS of pmaip1 after phf8 deletion,
resulting in a 70% downregulation of pmaip1 at differentia-
tion day 3 in the phf8-/Y cells (Fig. 5B). The pro-apoptotic
gene pmaip1 is, therefore, epigenetically regulated by the his-
tone demethylase, which subsequently affects the mesoder-
mal and cardiac differentiation.
pmaip1 is a Bcl2 homology domain 3 (BH3)-only protein
that acts as an important mediator of apoptosis [46]. Its
expression is regulated transcriptionally by various transcrip-
tion factors and, when present, it acts to promote cell death
in a variety of ways [21] including caspase 3 dependent [47]
and independent apoptosis [48] and autophagy [40]. Here, we
ﬁnd that PHF8 and its regulation on the pmaip1 promote
DNA fragmentation and cell death most likely through a cas-
pase 3-independent pathway. This conclusion is based on the
observation that neither the ratio of cleaved caspase 3 to
total caspase 3 [49, 50] nor PARP1, a downstream target of
caspase 3, is signiﬁcantly affected. While this may be
explained as the inhibitor of apoptosis proteins can counteract
the function of caspase 3 [51, 52], the exact mechanisms we
observed here need to be further explored.
Functionally, knockdown of pmaip1 confers signiﬁcant pro-
tection to apoptosis (Fig. 6B), while the increase in pmaip1
occurs concomitantly with the enhancement in apoptosis
observed during the early stage of cardiac differentiation (Fig.
4A--4C). The potential pmaip1-mediated apoptosis pathway
might be explained by the following possibilities: (i) similar as
BNIP3 (another BH3-only protein) which acts in the death of
cardiac myocytes during exposure to hypoxia and acidosis
without signiﬁcant caspase activation [53], pmaip1 might acti-
vate mitochondrial permeability transition pore but not mito-
chondrial apoptosis-inducing channel and causes the caspase
3-independent cell death [54]; and (ii) pmaip1 would induce
the direct DNA damage? which has been proved to mediate
the cell death pathway involved in the reactive oxygen spe-
cies generation in Soas-2 osteogenic sarcoma cells [55, 56].
Further studies are needed to elucidate the regulatory mecha-
nisms of pmaip1 on the caspase 3-independent cell death in
differentiating ESCs.
Our ﬁndings appear to contradict publications reporting
that PHF8 promotes neuronal differentiation of P19 cells [19].
Since the retinoic acid (RA) receptor was implicated in this pro-
cess and our mesodermal induction system does not utilize RA
[23], the differences are likely model system dependent, how-
ever, the role of RA requires further attention. Alternatively,
function and expression of PHF8 may differ or be gene speciﬁc
among cell types. In the undifferentiated state of mESC, PHF8 as
well as histone H3K27 demethylases UTX [13, 45] and JMJD3
[12] are dispensable to ESC proliferation (Fig. 3D, 3E) and apo-
ptosis (Fig. 4). PHF8, however, regulates the proliferation and
apoptosis of self-renewing cancer cells. It is highly expressed in
prostate cancer cells [57], Hela cells [58], esophageal squamous
cell carcinoma [59], and human nonsmall cell lung cancer cells
[60]. Knockdown of phf8 in these cancerous cells results in a
decrease of proliferation due to the poor cell cycle and the
induction of apoptosis, while we show here that knockout of
phf8 does not affect proliferation or cell cycle in undifferenti-
ated ESCs. These differences highlight the distinction in the
function and regulation of PHF8 between potentially tumori-
genic mESCs and cancer cells.
CONCLUSION
This study has identiﬁed a previously unrecognized function
of histone demethylase PHF8 in the mesodermal and cardiac
differentiation of ESCs through the control of apoptosis and
the regulation of a proapoptotic gene. Mechanistically, PHF8
promotes apoptosis by removing the repressive H3K9me2
mark from the TSS of a pro-apoptotic gene pmaip1. Loss of
this repressive mark permits or promotes pmaip1 transcrip-
tion, which promotes caspase 3-independent DNA fragmenta-
tion and cell death. Deletion of phf8, in contrast, represses
pmaip1 expression and reduces apoptosis in differentiating
cells, which leads to augmented mesodermal lineage speciﬁca-
tion and cardiac cell commitment (Fig. 7) but not to the early
ectodermal or endodermal differentiation. These results estab-
lish a new paradigm of the epigenetic control essential to the
early ESC differentiation and lineage commitment through
regulating apoptosis.
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